3-((2-Methyl-3-furyl)thio)-2-butanone
| Common Name: |
3-((2-Methyl-3-furyl)thio)-2-butanone |
| IUPAC Name: |
3-(2-methylfuran-3-yl)sulfanylbutan-2-one |
| Molecular Formula: |
C12H18O2 |
| SMILES: |
CC1=C(C=CO1)SC(C)C(=O)C |
| Inchi: |
1S/C9H12O2S/c1-6(10)8(3)12-9-4-5-11-7(9)2/h4-5,8H,1-3H3 |
| Inchi Key: |
AOEYNSLUBHRZPA-UHFFFAOYSA-N |
| Cas No: |
61295-44-1 |
| Name |
Value |
| Lipinski Violations |
0 |
| Ghose Violations |
0 |
| Veber Violations |
0 |
| Egan Violations |
0 |
| Muegge Violations |
1 |
| Name |
Value |
| Molecular Weight (g/mol) |
194.27 |
| Mass (g/mol) |
184.056 |
| Molar Refractivity |
58.02 |
| Net Charge |
|
| HBD |
|
| HBA |
2 |
| Rt Bonds |
5 |
| Rings |
1 |
| TPSA |
26.30 |
| Hetero Atoms |
3 |
| Heavy Atoms |
14 |
| Aromatic Heavy Atoms |
0 |
| Melting Point (°C) |
|
| Boiling Point (°C@760.00mm Hg) |
70.00 @ 0.75 mm Hg |
| Vapor Pressure (mmHg@25.00 °C) |
0.04 |
| Vapor Density (Air =1) |
|
| Fraction Csp3 |
0.58 |
| LogP |
2.658 |
| iLOGP |
2.86 |
| XLOGP3 |
2.96 |
| WLOGP |
2.99 |
| MLOGP |
2.56 |
| ESOL Log S |
-2.58 |
| ESOL Solubility (mg/ml) |
0.512 |
| ESOL Solubility (mol/l) |
0.003 |
| ESOL Class: esol_class |
Soluble |
| Ali Log S |
-3.18 |
| Ali Solubility (mg/ml) |
0.13 |
| Ali Solubility (mol/l) |
0 |
| Ali Class |
Soluble |
| Silicos-IT LogSw |
-2.17 |
| Silicos-IT Solubility (mg/ml) |
1.3 |
| Silicos-IT Solubility (mol/l) |
0.01 |
| Silicos-IT Class |
Soluble |
| Name |
Value |
| GI Absorption |
High |
| BBB Permeable |
1 |
| PgP Substrate |
0 |
| Log Kp (cm/s) |
-5.38 |
| Bioavailability Score |
0.55 |
| Caco2 |
1 |
| Human Intestinal Absorption |
1 |
| Plasm Protein Binding |
0.927 |
| CYP1A2 Inhibitor |
0 |
| CYP2C19 Inhibitor |
0 |
| CYP2C9 Inhibitor |
1 |
| CYP2D6 inhibitor |
0 |
| CYP3A4 inhibitor |
0 |
| Ames mutagenesis |
0 |
| Acute Oral Toxicity |
1.735 |
| Carcinogenicity (Binary) |
0 |
| Carcinogenicity (Trinary) |
Non-required |
| Eye Irritation |
1 |
| Hepatotoxicity |
0 |
| Androgen Receptor Binding |
0 |
| Aromatase Binding |
0 |
| Estrogen Receptor Binding |
0 |
| Glucocorticoid Receptor Binding |
0 |
| Thyroid Receptor Binding |
0 |
| BRCP inhibitor |
0 |
| BSEP inhibitor |
0 |
| OATP1B1 inhibitor |
1 |
| OATP1B3 inhibitor |
1 |
| OATP2B1 inhibitor |
0 |
| OCT1 inhibitor |
0 |
| OCT2 inhibitor |
0 |
